Eliza Wickham

Illumina (United States)

Papers

1

Total Citations

196

H-Index

1

About

Dr. Eliza Wickham is a leading figure in molecular pathology and translational genomics, best known for pioneering high-throughput gene expression analysis in archival clinical specimens. Her landmark 2004 paper, "Quantitative Gene Expression Profiling in Formalin-Fixed, Paraffin-Embedded Tissues Using Universal Bead Arrays," has garnered nearly 200 citations and revolutionized the field by demonstrating that degraded RNA from routine pathology samples could be reliably profiled on universal bead arrays. This breakthrough enabled researchers to unlock decades of archived tissue samples for large-scale biomarker discovery and validation, bridging a critical gap between clinical archives and modern genomic technologies. Dr. Wickham’s work has been instrumental in advancing personalized medicine, particularly in oncology, by facilitating the development of prognostic and predictive gene signatures from routinely collected biopsies. Her contributions have empowered countless studies correlating molecular profiles with long-term patient outcomes, making her a foundational figure in the integration of molecular diagnostics with clinical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
196
Total Citations
196
Avg Citations/Paper
🏆 Most Cited Paper
Quantitative Gene Expression Profiling in Formalin-Fixed, Paraffin-Embedded Tissues Using Universal Bead Arrays
196 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Illumina (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago